Vitamin D treatment for sepsis patients in intensive care
Treatments studied
Part of Infections clinical trials.
This study tests whether a special form of vitamin D can improve outcomes for patients with sepsis, a severe infection that can cause organ failure. The treatment is given to patients in the intensive care unit, and the study aims to see if it helps them recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the intensive care unit (ICU) with sepsis, a serious infection that affects your whole body.
- You have not had high calcium levels recently (a blood test will check this).
- You do not have severe chronic heart, kidney, or liver disease.
- You are not currently taking corticosteroids or other drugs that suppress the immune system.
- You do not have an autoimmune disease, cancer, or severe weight loss (cachexia).
- You have not taken active vitamin D in the last 4 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving very high doses of vitamin D to patients with sepsis in the intensive care unit (ICU) can improve their recovery. It focuses on adults aged 18 and older who have just been diagnosed with sepsis and are expected to stay in the ICU for at least a week.
This study looks at whether ionized calcium levels (a form of calcium in your blood) can help show how severe your sepsis is. By measuring it early, doctors might better understand your condition and guide treatment.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial tests if curcumin (a natural compound found in turmeric) can help critically ill patients fighting sepsis, a life-threatening response to infection. It is for adults who are already receiving food through a feeding tube in the ICU.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.